Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Jun 12;25(10):2024–2030. doi: 10.1016/j.bbmt.2019.06.004

Table 3a.

Pulmonary toxicity incidences

N eval Prob (95% CI) N eval Prob (95% CI) p-value
Disease type Malignant (N = 2452) Non-malignant (N = 2570)
Pneumonitis 2375 2508 <0.001
   100-day 6 (5-7)% 5 (4-5)%
   6 months 8 (7-9)% 5 (5-6)%
   1-year 9 (8-10)% 6 (5-7)%
Diffuse alveolar hemorrhage 2377 2509 0.39
   100-day 2 (1-2)% 2 (1-2)%
   6 months 2 (2-3)% 2 (1-2)%
   1-year 3 (2-3)% 2 (2-3)%
Pulmonary GVHD 2394 2541 <0.001
   100-day 1 (0-1)% 0 (0-0)%
   6 months 2 (2-3)% 1 (0-1)%
   1-year 3 (3-4)% 1 (1-2)%
Conditioning intensity MAC (N = 3554) RIC/NMA (N = 1143)
Pneumonitis 3533 1136 <0.001
   100-day 6 (5-7)% 3 (2-5)%
   6 months 7 (7-8)% 4 (3-5)%
   1-year 9 (8-10)% 5 (3-6)%
Diffuse alveolar hemorrhage 3535 1137 0.14
   100-day 2 (2-3)% 1 (1-2)%
   6 months 2 (2-3)% 1 (1-2)%
   1-year 3 (2-3)% 2 (1-3)%
Pulmonary GVHD 3493 1123 0.002
   100-day 1 (0-1)% 0 (0-1)%
   6 months 2 (1-2)% 1 (0-1)%
   1-year 3 (2-3)% 1 (1-2)%
Graft source BM/PBSC graft (N = 2933) Cord blood graft (N = 2089)
Pneumonitis 2885 1998 <0.001
   100-day 4 (3-5)% 7 (6-8)%
   6 months 5 (4-6)% 9 (7-10)%
   1-year 6 (5-7)% 10 (9-11)%
Diffuse alveolar hemorrhage 2887 1999 <0.001
   100-day 1 (1-1)% 3 (2-4)%
   6 months 1 (1-2)% 3 (3-4)%
   1-year 1 (1-2)% 4 (3-5)%
Pulmonary GVHD 2869 2063 0.48
   100-day 0 (0-0)% 1 (0-1)%
   6 months 1 (1-2)% 2 (1-2)%
   1-year 2 (2-3)% 2 (2-3)%
Age, years <1 (N = 623) 1 - <10 (N = 2381) 10 - <21 (N = 2018)
Pneumonitis 612 2307 1964 0.02
   100-day 8 (6-10)% 4 (4-5)% 6 (5-7)%
   6 months 8 (6-10)% 6 (5-7)% 7 (6-8)%
   1-year 9 (7-12)% 7 (6-8)% 8 (7-9)%
Diffuse alveolar hemorrhage 613 2309 1964 <0.001
   100-day 4 (3-6)% 1 (1-2)% 2 (1-2)%
   6 months 4 (3-6)% 2 (1-2)% 2 (1-3)%
   1-year 5 (3-7)% 2 (1-2)% 2 (2-3)%
Pulmonary GVHD 617 2358 1957 <0.001
   100-day 0 (0-1)% 0 (0-1)% 1 (0-1)%
   6 months 1 (0-1)% 1 (1-2)% 2 (1-2)%
   1-year 1 (0-2)% 2 (1-2)% 3 (2-4)%